Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

COVID19

FDA Panel Votes in Favor of COVID-19 Pill But With Concerns

Diana Ernst, RPh

June 10, 2022

Molnupiravir is an orally administered form of a ribonucleoside analogue that inhibits the replication of SARS-CoV-2.

Respiratory

FDA Tells Philips Respironics to Increase Awareness of Product Recall

Diana Ernst, RPh

March 15, 2022

The Agency issued the notification order as it deemed the Company’s notification efforts to be inadequate.

COVID19

Millions of Courses of Molnupiravir Delivered; HHS Sets Up COVID-19 Therapeutics Locator

Diana Ernst, RPh

February 22, 2022

Molnupiravir is an orally administered form of a ribonucleoside analogue that inhibits the replication of SARS-CoV-2.

COVID19

Famotidine Study Shows Some Benefit in Mild to Moderate COVID-19

Diana Ernst, RPh

February 14, 2022

The randomized, double-blind, placebo controlled, fully remote study was led by The Feinstein Institutes for Medical Research at Northwell Health and Cold Spring Harbor Laboratory.

COVID19

Molnupiravir Active Against Omicron, According to Preclinical Studies

Diana Ernst, RPh

February 1, 2022

Molnupiravir is a nucleoside analogue that inhibits SARS-CoV-2 replication by viral mutagenesis.

COVID19

FDA Greenlights Use of Veklury for Outpatient COVID-19 Treatment

Diana Ernst, RPh

January 26, 2022

Veklury is a nucleotide analogue with broad spectrum antiviral activity.

COVID19

Oral Antiviral Treatments for COVID-19: Molnupiravir and Paxlovid

Diana Ernst, RPh

January 20, 2022

Concise drug information for molnupiravir and Paxlovid; the FDA granted Emergency Use to both oral antiviral therapies.

COVID19

COVID-19 Vaccination Linked to Small Increase in Menstrual Cycle Length

Diana Ernst, RPh

January 13, 2022

Data from the Natural Cycles app was analyzed for an association between COVID-19 vaccination menstrual cycle changes.

COVID19

Contraindication Added to Janssen COVID-19 Vaccine Fact Sheet

Diana Ernst, RPh

December 20, 2021

Cases of TTS have been reported in both males and females.

COVID19

Early Data Suggest Potential Benefit of Heterologous Boosting for COVID-19

Diana Ernst, RPh

December 14, 2021

The independent study conducted by Dan Barouch, MD, PhD, et al of Beth Israel Deaconess Medical Center included a subset of participants from the COV2008 study.

Next post in COVID19